Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CATALIS Quebec does not conduct its own drug development but has successfully accelerated the launch and execution of numerous industry-sponsored clinical trials in Quebec. Its FAST TRACK program aims to authorize new studies within eight weeks and has attracted major pharmaceutical partners to the province. The initiative has contributed to increased private investment and improved operational excellence in the region’s life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CATALIS Quebec.